| Literature DB >> 31934309 |
Chia-Yin Chiang1, Yung-Hao Ching2, Ting-Yan Chang1, Liang-Shuan Hu1, Yee Siang Yong2, Pei Ying Keak2, Ivana Mustika2, Ming-Der Lin2, Ben-Yang Liao1.
Abstract
In the last few decades, reverse genetic and high throughput approaches have been frequently applied to the mouse (Mus musculus) to understand how genes function in tissues/organs and during development in a mammalian system. Despite these efforts, the associated phenotypes for the majority of mouse genes remained to be fully characterized. Here, we performed an integrated transcriptome-phenome analysis by identifying coexpressed gene modules based on tissue transcriptomes profiled with each of various platforms and functionally interpreting these modules using the mouse phenotypic data. Consequently, >15,000 mouse genes were linked with at least one of the 47 tissue functions that were examined. Specifically, our approach predicted >50 genes previously unknown to be involved in mice (Mus musculus) visual functions. Fifteen genes were selected for further analysis based on their potential biomedical relevance and compatibility with further experimental validation. Gene-specific morpholinos were introduced into zebrafish (Danio rerio) to target their corresponding orthologs. Quantitative assessments of phenotypes of developing eyes confirmed predicted eye-related functions of 13 out of the 15 genes examined. These novel eye genes include: Adal, Ankrd33, Car14, Ccdc126, Dhx32, Dkk3, Fam169a, Grifin, Kcnj14, Lrit2, Ppef2, Ppm1n, and Wdr17. The results highlighted the potential for this phenome-based approach to assist the experimental design of mutating and phenotyping mouse genes that aims to fully reveal the functional landscape of mammalian genomes.Entities:
Keywords: Expression profile; Functional genomics; Mammals; Modularity; Retina; Systems biology
Year: 2019 PMID: 31934309 PMCID: PMC6951830 DOI: 10.1016/j.csbj.2019.12.009
Source DB: PubMed Journal: Comput Struct Biotechnol J ISSN: 2001-0370 Impact factor: 7.271
Fig. 1Genes associated with the “eye” module. (A) Genes with different levels of consistency in being located in the eye module across the three platforms are shown according to their confidence scores [e.g., high (dark red), medium (red), low (pink)] for predicted retinal function. (B-D) Genes with higher confidence scores tend to have greater values of (B) connectivity, (C) betweenness, and (D) closeness, thereby indicating that they are more likely to be the central node of the module(s). In (B–D), P-values were determined with the Mann-Whitney U test and are associated with the arched lines that indicate the values that were compared. The corresponding weighted coexpression networks used to generate the data are indicated under each panel. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
The human orthologs of mouse genes with predicted eye functions are enriched with genes cataloged in RetNet (dubbed “RetNet”) or HPO-defined eye disease genes (dubbed “HPO”).
| Confidence score of predicted eye functions | ||||
|---|---|---|---|---|
| All orthologs | Orthologs without any previously reported eye phenotype in mice | |||
| RetNet | HPO | RetNet | HPO | |
| High | <10−11 | <10−6 | <10−2 | 0.02 |
| High + Medium | <10−12 | <10−9 | <10−2 | 0.01 |
| High + Medium + Low | <10−4 | <10−10 | 0.12 | n.s. |
P-value was obtained under the null hypothesis of no enrichment by Fisher’s exact test (n.s.: not significant).
List of candidate genes underlying proper eye development and function in mice. Only genes without a previously reported gene deletion phenotype in any of the 47 selected tissues in mice are included in this list.
| MGI Gene symbol | Number of ortholog(s) | Characterized vision/eye-related phenotypes due to mutations (or reduced expression, if noted) [gene symbol, species | |
|---|---|---|---|
| Human | Zebrafish | ||
| 1 | 2 | Unreported | |
| 1 | 2 | Knockdown caused a sever delay in photoresponse recovery [arr3, zebrafish] | |
| 1 | 2 | Retinitis pigmentosa 49, | |
| 1 | 1 | Cataracts and microphthalmia, | |
| 1 | 1 | Congenital cataracts, | |
| 0 | 0 | Unreported | |
| 1 | 0 | Unreported | |
| 1 | 1 | Unreported | |
| 1 | 1 | Unreported | |
| 1 | 2 | Retinal cone dystrophy 3B, RCD3B [KCNV2, human] | |
| 1 | 2 | Unreported until 2018; visual acuity impairments in optokinetic response [ | |
| 1 | 1 | Unreported | |
| 1 | 0 | None [ps. no eye abnormality detected in mice | |
| 1 | 1 | Incomplete achromatopsia | |
| 1 | 2 | Unreported | |
| 1 | 2 | Unreported | |
| 1 | 1 | Unreported until 2017; ectopic expression of nonrod genes and rod photoreceptor cell dysfunction [ | |
| 1 | 2 | Early pathological change in the development of aged-related macular degeneration [EAAT5, human] | |
| 1 | 2 | Congenital cataract and intellectual disability [STX3, human] | |
| 1 | 0 | Unreported | |
| 1 | 1 | Unreported until 2019, concomitant strabismus [TSPAN10, human] | |
| 0 | 0 | Unreported | |
| 1 | 1 | Unreported | |
| 1 | 1 | Unreported | |
| 1 | 1 | Unreported | |
| 0 | 0 | Unreported | |
| 1 | 1 | Pediatric or age-related cataracts CATARACT 17 [CRYBB1, human] | |
| 1 | 2 | Unreported | |
| 0 | 0 | Unreported | |
| 1 | 2 | Unreported | |
| 1 | 2 | Unreported | |
| 1 | 3 | Unreported | |
| 1 | 2 | Unreported | |
| 1 | 0 | Unreported | |
| 1 | 1 | Unreported | |
| 1 | 0 | Unreported | |
| 1 | 2 | Vitelliform macular dystrophies [IMPG1, human] | |
| 1 | 3 | Unreported | |
| 1 | 1 | Retinitis pigmentosa 62, RP62 [MAK, human] | |
| 1 | 0 | Unreported | |
| 1 | 0 | Unreported | |
| 0 | 1 | Unreported | |
| 1 | 0 | Unreported | |
| 1 | 1 | Knockdown suppressed retina regeneration [pou6f2, zebrafish] | |
| 1 | 1 | Retinitis punctata albescens [RRH, human] | |
| 1 | 1 | Expression reduction marks the occurrence of retinal detachment [SLCO4A1, human] | |
| 1 | 1 | Unreported | |
| 1 | 1 | Evolutionarily reduced expression linked to weakened vision during domestication [vit, chicken] | |
| 1 | 1 | Unreported | |
| 1 | 0 | Unreported | |
See Tables S11 and S12 for the corresponding MGI ID and full gene name.
See Table S15 for the corresponding gene IDs of the orthologs.
Human: Homo sapiens; mouse: M. musculus; chicken: Gallus gallus; zebrafish: Danio rerio.
Indicates genes which were functionally validated in zebrafish in the present study.
Eye candidate genes with a medium or a high confidence score when coexpressed gene modules were defined by PGCNA.
Fig. 2Consequences of knocking down zebrafish orthologs of mouse candidate eye genes with MO. (A) Groups of MO for two candidate genes (Grifin, Tldc1) exhibited a greater proportion of developmentally delayed embryos than the control groups. The numbers of embryos used to calculate the proportions are indicated for each bar. (B) The left side of each embryo was imaged and a line was drawn across the centroids of the lens and the otic vesicle to measure gross eye morphology. Based on this line, eye (or lens) size was defined as the length (in pixels) of the red (or green) dashed line that starts from the anterior boundary and extends to the posterior boundary of the eye (or lens). The lens/eye ratio was calculated by lens size divided by eye size. (C) Groups of MO for 11 candidate genes induced a significant reduction in eye size. (D) Groups of MO for 5 candidate genes induced aberrant lens/eye ratios. In (C–D), violin plots present the values for (C) eye size and (D) lens/eye ratios. In (A, C, D), P-values were determined with Fisher’s exact test (A) or the Mann-Whitney U test (C, D). These values are associated with arched gray lines at the top of each panel which indicate the values that were compared. At the bottom of the plots, names of the corresponding mouse genes (black font) which were validated with MO are indicated at the bottom of the plots. The names of the MO groups (grey font) are specified only when multiple MO were designed for a focal gene. Only comparisons that differed significantly are shown (Figs. S8–S22 present the complete set of data). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Fig. 3Histological examination of retinal structures in morphants of ankrd33aa and ankrd33ab. (A) The eye section of control MO-injected embryos. The retina of all control embryos (13/13) showed well-structured lamination. (B,C,D) Eye sections of ankrd33aa morphant embryos. The retina of ankrd33aa morphant embryos could be (B) normal (2/13), (C) disorganized in plexiform layers (9/13), or (D) severely degenerated (2/13). (E,F) Eye sections of ankrd33ab morphant embryos. The retina of ankrd33ab morphant embryos could be (E) normal (7/16) or (F) underdeveloped with an enucleation defect in lens fiber cells (yellow arrows) (9/16). In (A–F), coronal sections of the eye were performed to reveal retinal lamination by hematoxylin and eosin staining. The area within yellow rectangle is enlarged to show the retina structure. The anterior is to the top. Scale bars: 20 μm. RPE: retinal pigment epithelium; PCL: photoreceptor cell layer; ONL: outer nuclear layer; OPL: outer plexiform layer; INL: inner nuclear layer; IPL: inner plexiform layer; GCL: ganglion cell layer. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Candidate genes whose human ortholog were found to be located in the genomic regions mapped by congenital eye diseases in humans.
| Gene symbol | Mapped congenital eye diseases (OMIM ID) | References |
|---|---|---|
| Cataract 35 (OMIM: 609376) | ||
| Cataract 35 (OMIM: 609376) | ||
| Microphthalmia with coloboma 2 | ||
| Dominant cystoid macular dystrophy (OMIM: 153880) | ||
| Cone-rod dystrophy 17 (OMIM: 615163) | ||
| Usher syndrome, type IK (OMIM: 614990) | ||
| Glaucoma 1B, primary open angle, adult onset; (OMIM: 606689) | ||
| Glaucoma 1 K, primary open angle, juvenile-onset (OMIM 608696) | ||
| Retinitis pigmentosa 29 (OMIM: 612165) | ||